These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 2351315)
1. Neoadjuvant chemotherapy in stage X ovarian carcinoma. Chambers JT; Chambers SK; Voynick IM; Schwartz PE Gynecol Oncol; 1990 Jun; 37(3):327-31. PubMed ID: 2351315 [TBL] [Abstract][Full Text] [Related]
2. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878. Wadler S; Yeap B; Vogl S; Carbone P Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766 [TBL] [Abstract][Full Text] [Related]
3. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration. Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679 [TBL] [Abstract][Full Text] [Related]
5. Medical therapy of advanced malignant epithelial tumours of the ovary. Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983 [TBL] [Abstract][Full Text] [Related]
6. Long term results of cyclophosphamide, adriamycin and platinum chemotherapy in advanced epithelial ovarian cancer. Harding M; Milsted R; Hole D; Cordiner J; Barr W; Soukop M; Kennedy J; Soutter WP; Kaye S Ann Oncol; 1991 Mar; 2(3):231-3. PubMed ID: 2043495 [TBL] [Abstract][Full Text] [Related]
7. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gadducci A; Landoni F; Sartori E; Maggino T; Zola P; Gabriele A; Rossi R; Cosio S; Fanucchi A; Tisi G Gynecol Oncol; 2001 May; 81(2):150-9. PubMed ID: 11330942 [TBL] [Abstract][Full Text] [Related]
8. Randomized prospective trial of 5 versus 10 cycles of cyclophosphamide, doxorubicin, and cisplatin in advanced ovarian carcinoma. Hakes TB; Chalas E; Hoskins WJ; Jones WB; Markman M; Rubin SC; Chapman D; Almadrones L; Lewis JL Gynecol Oncol; 1992 Jun; 45(3):284-9. PubMed ID: 1612505 [TBL] [Abstract][Full Text] [Related]
9. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Ho CM; Huang YJ; Chen TC; Huang SH; Liu FS; Chang Chien CC; Yu MH; Mao TL; Wang TY; Hsieh CY Gynecol Oncol; 2004 Jul; 94(1):197-203. PubMed ID: 15262142 [TBL] [Abstract][Full Text] [Related]
10. Platinum-based chemotherapy for advanced-stage serous ovarian carcinoma of low malignant potential. Barakat RR; Benjamin I; Lewis JL; Saigo PE; Curtin JP; Hoskins WJ Gynecol Oncol; 1995 Dec; 59(3):390-3. PubMed ID: 8522261 [TBL] [Abstract][Full Text] [Related]
18. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer. Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134 [TBL] [Abstract][Full Text] [Related]
19. [Tolerance and role of irradiation in the treatment of epithelial cancer of the ovary]. Quétin P; Marchal C; Hoffstetter S; Cutuli B; Beckendorf V; Lapeyre M; Peiffert D; Bey P Cancer Radiother; 1998; 2(4):366-74. PubMed ID: 9755750 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma. Kuhn W; Rutke S; Späthe K; Schmalfeldt B; Florack G; von Hundelshausen B; Pachyn D; Ulm K; Graeff H Cancer; 2001 Nov; 92(10):2585-91. PubMed ID: 11745193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]